Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
National Research ( (NRC) ) just unveiled an announcement.
National Research Corporation reported a decrease in revenue and earnings for the fourth quarter of 2024 compared to the same period in 2023. The company returned $10.1 million to shareholders through dividends and stock repurchases, indicating a strategic focus on delivering value to stakeholders despite financial challenges.
More about National Research
NRC Health, operating for over 40 years, specializes in humanizing healthcare by aiding organizations to understand individual patient needs. The company emphasizes a patient-focused approach, market research, and consumer preferences to enhance healthcare experiences and outcomes.
YTD Price Performance: 3.88%
Average Trading Volume: 92,038
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $421.6M
Find detailed analytics on NRC stock on TipRanks’ Stock Analysis page.
